Explore the research on oxytocin's role beyond labor and bonding as Anna Cabeca, DO, FACOG, triple board certified ob-gyn, sheds light on its impact on longevity, sexual health, and overall well-being at the A4M conference in Las Vegas.
Contemporary OB/GYN:
Hi, I'm Dr. Michael Krychman, Digital Editor for Contemporary OB/GYN. I am here at the A4M conference in Las Vegas, which is an anti-aging and longevity conference. It’s very exciting, lots of people, lots of clinicians, lots of new and exciting data being presented. I'm here with one of our esteemed speakers. Dr. Anna. Please tell us a little bit about yourself, give us an introduction, and tell us about the amazing lectures that you are going to be giving.
Anna Cabeca, DO, FACOG:
Yeah, thank you. I love being here, and one of the topics I'm very passionate about is connection and how the hormone of connection, oxytocin is very lifesaving. I'm a triple board-certified OBGYN. I trained at Emory University in Atlanta, Georgia, and I went on to specialize in sexual health and bioidentical hormone replacement therapies. And the one thing that they're working with women to restore their hormones, I always say it takes more than hormones to fix your hormones, and there's a hierarchy of hormones, with our reproductive hormones, and then the control hormones such as insulin and cortisol, and then the master hormone oxytocin. And as obstetricians, we know a lot about oxytocin, we use it in labor, we know it's the hormone of connection and bonding, for the mom to bond with her baby. It's the hormone of orgasm, which connects us to our partner, also the feel good hormone. And scientific research has continued to be developed and ongoing in oxytocin, and what we know is it's a hormone of longevity, it's a hormone of muscular repair, it’s a hormone of brain learning and memory of cognition. So, the more oxytocin we have in our life, the healthier, the better, and the more life is worth living.
Contemporary OB/GYN:
It's amazing and exciting information. And I know most of our general clinicians don't really know much about oxytocin, they know about its use and labor, and maybe a little bit about pair bonding, but the data on sexual arousal, sexual connection, bonding is really outstanding. And I think we need to really refocus on oxytocin and what is happening. I know that there's some really interesting medications that are being developed. One in the field of sexual function that I know of is a topical application to the nipples, which actually has been shown to improve arousal, and it's really about this oxytocin pathway. So again, I think it’s amazing information, really exciting, not only focusing on estrogen and progesterone and testosterone as gynecologist but really looking outside the box. So, glad you're doing all this wonderful lecturing and research and helping move the field to the next level. Thanks again.
Cabeca:
Thank you.
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More